Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Hidden lymphatic signal amplifier could inform treatments for lymphedema and cancer metastasis (opens in a new tab)

medicalxpress.com · 2026-10-02

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 4 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Four of six claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 4 supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredLymphatic vessels act as the body's drainage system, and impaired lymphatic drainage can lead to lymphedema, while excessive lymphatic vessel growth around tumors can facilitate cancer metastasis.View evidenceHide evidence

Why this verdict

The supplied profile supports that VEGF-C/VEGFR-3 regulate lymphangiogenesis, but it does not verify the broader background statements that lymphatic vessels are the body's drainage system, that impaired drainage leads to lymphedema, or that excessive lymphatic growth around tumors facilitates metastasis. Those may be true background claims, but they are not established in the abstract-level paper profile.

1

Study evidence

A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.

“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
Claim 2 of 6Not coveredThe article says targeting this clustering process may eventually provide a strategy to enhance lymphangiogenic signaling when lymphatic vessel formation is insufficient or suppress it when excessive lymphatic vessels form around tumors.View evidenceHide evidence

Why this verdict

The profile supports a broad, hedged translational implication: structural insights may provide a blueprint for therapeutics that modulate lymphatic vascular signaling. However, the abstract-level profile does not verify the specific proposed disease-use cases of enhancing signaling for insufficient lymphatic vessel formation or suppressing excessive lymphatic vessels around tumors. The claim is hedged, but the detailed application framing is not verifiable from the supplied abstract-depth evidence.

1

Study evidence

First cryo-EM structure reported of the human VEGFR-3 full ectodomain in complex with VEGF-C, revealing a canonical ligand-induced 2:2 hetero-tetrameric assembly.

“we report the first cryo-EM structure of the human VEGFR-3 full ectodomain in complex with VEGF-C”
2

Study evidence

A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.

“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
Claim 3 of 6SupportedKorean researchers discovered that VEGF-C brings two VEGFR-3 receptors together, and the resulting VEGF-C–VEGFR-3 complexes further cluster to amplify signaling.View evidenceHide evidence

Why this verdict

The profile states that VEGF-C–VEGFR-3 forms a canonical ligand-induced 2:2 hetero-tetrameric complex and that these complexes self-assemble into higher-order assemblies. It also reports structure-guided mutagenesis and optogenetic assays supporting a critical role for cis-clustering in signaling amplification.

1

Study evidence

First cryo-EM structure reported of the human VEGFR-3 full ectodomain in complex with VEGF-C, revealing a canonical ligand-induced 2:2 hetero-tetrameric assembly.

“we report the first cryo-EM structure of the human VEGFR-3 full ectodomain in complex with VEGF-C”
2

Study evidence

A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.

“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
Claim 4 of 6SupportedA joint team led by Ho Min Kim and Sangkyu Lee determined the 3D structure of the VEGF-C–VEGFR-3 complex and identified higher-order clustering as a structural mode that amplifies signaling.View evidenceHide evidence

Why this verdict

The scientific portion of the claim is supported: the profile reports the first cryo-EM structure of the human VEGFR-3 ectodomain bound to VEGF-C and identifies higher-order cis-clustering as a mechanism for signal amplification. The supplied scientific profile does not independently encode the named leadership details, but the core paper-finding claim is supported.

1

Study evidence

First cryo-EM structure reported of the human VEGFR-3 full ectodomain in complex with VEGF-C, revealing a canonical ligand-induced 2:2 hetero-tetrameric assembly.

“we report the first cryo-EM structure of the human VEGFR-3 full ectodomain in complex with VEGF-C”
2

Study evidence

A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.

“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
Claim 5 of 6SupportedThe researchers used cryogenic electron microscopy and also altered receptor-contact regions and used light to control receptor clustering to test whether clustering amplifies signaling.View evidenceHide evidence

Why this verdict

The profile describes single-particle cryo-EM, structure-guided mutagenesis of receptor interface regions including the D5/WTP motif, and real-time optogenetic assays used to test whether enforced receptor clustering drives activation and whether cis-clustering amplifies signaling.

1

Study evidence

First cryo-EM structure reported of the human VEGFR-3 full ectodomain in complex with VEGF-C, revealing a canonical ligand-induced 2:2 hetero-tetrameric assembly.

“we report the first cryo-EM structure of the human VEGFR-3 full ectodomain in complex with VEGF-C”
2

Study evidence

A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.

“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
Claim 6 of 6SupportedThe story says the study did not demonstrate therapeutic effects for lymphedema or inhibition of cancer metastasis, and that further research will be required before clinical application.View evidenceHide evidence

Why this verdict

This caveat is consistent with the supplied profile, which frames the work as basic structural and in vitro/cell-based functional research and notes no in vivo, human-subject, or therapeutic validation. The profile supports that clinical application would require further research, though full-paper auditing would be needed to confirm every absence claim beyond the abstract-level summary.

1

Study evidence

A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.

“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The functional evidence specifically supports cis-clustering as critical for signaling amplification, while the trans-like assembly appears dispensable for activation.

    The story reflects clustering generally but does not capture the paper’s distinction between cis-clustering and trans-like clustering, including the reported dispensability of trans-like clustering.

    From cryo-EM structural and structure-guided functional analysis; Structure-guided mutagenesis and optogenetic clustering in

  • A membrane-proximal VEGFR-3 D5-domain interface mediated by a specific WTP motif is identified as a driver of cis-clustering.

    The story describes receptor-contact regions at a high level but does not mention the D5-domain interface or WTP motif, which are specific mechanistic details in the profile.

    From cryo-EM structural and structure-guided functional analysis; Structure-guided mutagenesis and optogenetic clustering in

  • The paper includes a secondary structural explanation for VEGF-C receptor specificity, centered on the VEGF-C N-terminal α1 helix and VEGFR D1–D2/D2 features.

    The story focuses on VEGFR-3 activation and clustering and does not cover the paper’s secondary specificity analysis comparing VEGFR-3/VEGFR-2 with VEGFR-1.

    From in vitro

4 things the story did carry across
  • First cryo-EM structure of the human VEGFR-3 full ectodomain bound to VEGF-C, showing a canonical ligand-induced 2:2 VEGF-C:VEGFR-3 complex.
  • Canonical 2:2 VEGF-C:VEGFR-3 complexes self-assemble into higher-order assemblies, supporting a shift from a simple dimerization model to a dimer-to-cluster activation model.
  • Structure-guided perturbations of receptor-contact regions and real-time optogenetic receptor-clustering assays were used to test the functional role of clustering.
  • The evidence is abstract-level basic structural and cell-based mechanistic work, with no therapeutic demonstration or clinical validation reported in the supplied profile.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroDetermine the structural basis of human VEGFR-3 activation by VEGF-C, including canonical 2:2 complex formation and higher-order receptor clustering architectures (cis-cluster and trans-like cluster).cryo-EM structural and structure-guided functional analysisExpand

In plain English

The paper reports the first cryo-EM structure of the human VEGFR-3 full ectodomain bound to VEGF-C, showing a canonical ligand-induced 2:2 hetero-tetramer that further self-assembles into distinct higher-order assemblies (a lateral cis-cluster and an inverted trans-like-cluster). Structural analysis implicates the VEGF-C N-terminal α1 helix and receptor D2 domains in ligand-receptor specificity (VEGFR-3/VEGFR-2 versus VEGFR-1) and identifies a membrane-proximal D5–D5 interface mediated by a specific 'WTP motif' as a driver of cis-clustering. Structure-guided mutagenesis and real-time optogenetic assays are reported to support a critical role for cis-clustering in signal amplification, with enforced clustering sufficient to drive robust activation while trans-like clustering appears dispensable. The authors frame these results as a shift from a 'monomer-to-dimer' to a 'dimer-to-cluster' activation paradigm.

Key findings

  • First cryo-EM structure reported of the human VEGFR-3 full ectodomain in complex with VEGF-C, revealing a canonical ligand-induced 2:2 hetero-tetrameric assembly.
  • Canonical 2:2 hetero-tetrameric complexes self-assemble into distinct higher-order assemblies described as a lateral cis-cluster and an inverted trans-like-cluster.
“we report the first cryo-EM structure of the human VEGFR-3 full ectodomain in complex with VEGF-C”
What this piece can’t prove
  • Abstract does not report cryo-EM map resolution, model validation statistics, or detailed reconstruction parameters.
  • The abstract does not specify experimental contexts (e.g., biochemical versus cellular assays) or controls used for the functional studies.

2 further details could not be confirmed from the summary.

2in vitroExplain ligand/receptor specificity (VEGF-C preference for VEGFR-3/VEGFR-2 over VEGFR-1) via structural determinants centered on the VEGF-C N-terminal α1 helix and receptor D1–D2 features.Expand

In plain English

Using the cryo-EM structure of the human VEGFR-3 full ectodomain bound to VEGF-C and structure-based comparisons across VEGF receptors, the authors attribute VEGF-C's preference for VEGFR-3 and VEGFR-2 (over VEGFR-1) to the positioning of the ligand's N-terminal α1 helix: this helix is accommodated by the D2 domains of VEGFR-3 and VEGFR-2 but is sterically excluded by a protruding D1–D2 connecting loop in VEGFR-1.

Key findings

  • The specificity of VEGF-C for VEGFR-3 and VEGFR-2 over VEGFR-1 is primarily governed by the ligand's N-terminal α1 helix: D2 domains of VEGFR-3 and VEGFR-2 structurally accommodate this helix, whereas the protruding D1–D2 connecting loop of VEGFR-1 sterically excludes it.
“specificity of VEGF-C for VEGFR-3 and VEGFR-2 over VEGFR-1 is mainly governed by its N-terminal α1 helix”
What this piece can’t prove
  • The abstract does not report resolution details or whether comparable full-ectodomain structures for VEGFR-1/2 in the same ligand-bound state were determined experimentally; cross-receptor comparisons may rely on existing structures or models.

2 further details could not be confirmed from the summary.

3in vitroTest the functional importance of cis-clustering (vs trans-like clustering) for signaling amplification and receptor activation using structure-guided perturbations and real-time optogenetic activation assays.Structure-guided mutagenesis and optogenetic clustering in cell-based receptor activation assays (in vitro)Expand

In plain English

Structure-guided mutagenesis of a membrane-proximal D5-domain 'WTP motif' and real-time optogenetic receptor-clustering assays in cell-based systems indicate that cis-clustering of VEGFR-3 is a key driver of signaling amplification and receptor activation, that enforced clustering is sufficient to produce robust activation, and that the identified trans-like higher-order assembly is dispensable for activation (abstract-level evidence).

Key findings

  • A specific neighbor–neighbor interface in the VEGFR-3 membrane-proximal D5 domain, mediated by a 'WTP motif', was identified as a structural driver of lateral cis-clustering of canonical VEGF-C:VEGFR-3 2:2 complexes.
  • Structure-guided mutagenesis of the D5 'WTP motif' and cell-based signaling assays indicate cis-clustering is critical for signaling amplification of VEGFR-3.
“mediated by a specific 'WTP motif,' as a key driver of cis-clustering”
What this piece can’t prove
  • The scope appears to be in vitro / cell-based assays; abstract does not report in vivo or human-subject functional validation.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 36 candidate papers

SelectedOpen access

Structural Basis of Lymphangiogenic Receptor VEGFR-3 Activation Mediated by Distinctive Clustering of the Ligand-Receptor Complex.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany) · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

Author response for "Improved Oxygenation and Hemocompatibility for Microfluidic Artificial Lung via Membrane Microstreaming"

2026 · Crossref

Source (opens in a new tab)
Candidate

Author Index

2026 2Nd International Conference on IOT, Data Science and Advanced Computing (IDSAC) · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Advanced Wound Care Dressing Against Laser Patterned Mesh Foam Dressing OLEDs Patch"

2026 · Crossref

Source (opens in a new tab)

And 30 more candidates considered.